NZ740756A - Nanoparticulate composition containing antibiotics for intramammary administration in animals - Google Patents

Nanoparticulate composition containing antibiotics for intramammary administration in animals

Info

Publication number
NZ740756A
NZ740756A NZ74075611A NZ74075611A NZ740756A NZ 740756 A NZ740756 A NZ 740756A NZ 74075611 A NZ74075611 A NZ 74075611A NZ 74075611 A NZ74075611 A NZ 74075611A NZ 740756 A NZ740756 A NZ 740756A
Authority
NZ
New Zealand
Prior art keywords
mastitis
animals
composition containing
containing antibiotics
nanoparticulate composition
Prior art date
Application number
NZ74075611A
Inventor
Raquel Silva Araújo
Humberto De Mello Brandão
Vanessa Carla Furtado Mosqueira
Original Assignee
Empresa Brasileira De Pesquisa Agropecuaria Embrapa
Fund Amparo Pesquisa Estado Minas Gerais Fapemig
Univ Federal Ouro Preto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BRC11002601A external-priority patent/BRPI1002601E2/en
Application filed by Empresa Brasileira De Pesquisa Agropecuaria Embrapa, Fund Amparo Pesquisa Estado Minas Gerais Fapemig, Univ Federal Ouro Preto filed Critical Empresa Brasileira De Pesquisa Agropecuaria Embrapa
Publication of NZ740756A publication Critical patent/NZ740756A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed are two types of polymer nanocapsules to encapsulate cloxacillin benzathine, an antimicrobial drug. Also disclosed are methods of treating mastitis in dairy cattle. More specifically, this disclosure relates to a new form of treatment for mastitis in dairy cattle. Two nanocapsule formulations have been developed and can be used to encapsulate various drugs, besides cloxacillin benzathine, providing a new therapy for mastitis in cows, avoiding the inconvenience of the use of high doses of drugs used in conventional formulations, thus contributing to an improvement in milk quality.
NZ74075611A 2010-06-01 2011-06-01 Nanoparticulate composition containing antibiotics for intramammary administration in animals NZ740756A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRC11002601A BRPI1002601E2 (en) 2010-06-01 2010-06-01 nanostructured composition for veterinary use for drug administration
NZ72366111 2011-06-01

Publications (1)

Publication Number Publication Date
NZ740756A true NZ740756A (en) 2019-11-29

Family

ID=68652889

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ74075611A NZ740756A (en) 2010-06-01 2011-06-01 Nanoparticulate composition containing antibiotics for intramammary administration in animals

Country Status (1)

Country Link
NZ (1) NZ740756A (en)

Similar Documents

Publication Publication Date Title
BRPI1002601A2 (en) preparation product and process and characterized cloxacillin-containing polymeric nanocapsules applicable to the treatment of bovine mastitis
NZ707003A (en) Treatment and prevention of mastitis
RU2662300C2 (en) Methods of treating microbial infections, including mastitis
JP2014509659A5 (en)
NZ707377A (en) Combination therapy methods for treating proliferative diseases
MY188825A (en) High-concentration monoclonal antibody formulations
CY1105202T1 (en) DISPERSED PHARMACEUTICAL COMPOSITIONS
MX2017005425A (en) Methods and compositions particularly for treatment of attention deficit disorder.
RU2017113354A (en) INJECTION MICROPARTICLES FOR SUPERLOCALIZED RELEASE OF THERAPEUTIC MEDICINES
MX341660B (en) Ghrelin receptor agonist for treatment of dyscrasia.
MX2015015176A (en) Antimicrobial compositions and methods for their production.
MX2009012054A (en) Methods of treatment using intravenous formulations comprising temozolomide.
WO2016004216A3 (en) Hydrogels for treating and ameliorating infections and methods of making and using them
NZ740756A (en) Nanoparticulate composition containing antibiotics for intramammary administration in animals
MX2018010768A (en) Bioavailable polyamines.
WO2012009542A3 (en) Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration
WO2015011653A9 (en) pH RESPONSIVE ORAL POLYMERIC PHARMACEUTICAL DOSAGE FORM
EA201590350A1 (en) PEPTIDE COMBINATIONS WITH A CYCLIZED MAIN CHAIN
RO134199A3 (en) Nanocomposite composition for intramammary administration in cows suffering from mastitis
RU2008152691A (en) METHOD FOR PREVENTION AND TREATMENT OF MASTITIS IN COWS
EA201791458A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT
Nurhayati et al. Controlling subclinical mastitis by antibiotic application during dry period of dairy cow
PH12014501822A1 (en) Oral formulation comprising lansoprazole and the preparation method thereof
Ijaz et al. Treatment of chronic mastitis in a dairy cow: A case report
RU2018109421A (en) LYSOBACTIN FOR APPLICATION FOR TREATMENT OF Bovine mastitis

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 01 JUN 2021 BY BALDWINS INTELLECTUAL PROPERTY

Effective date: 20200331

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 JUN 2022 BY COMPUTER PACKAGES INC

Effective date: 20210517

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 JUN 2023 BY COMPUTER PACKAGES INC

Effective date: 20220519

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 JUN 2024 BY COMPUTER PACKAGES INC

Effective date: 20230530